Aller au contenu principal
Accès ouvert déclaré 2024 article

Novel loci and biomedical consequences of iron homoeostasis variation

10Citations signalées — pas une note de qualité
106Institutions déclarées
14Pays d’affiliation déclarés

Résumé fourni par la source

Iron homoeostasis is tightly regulated, with hepcidin and soluble transferrin receptor (sTfR) playing significant roles. However, the genetic determinants of these traits and the biomedical consequences of iron homoeostasis variation are unclear. In a meta-analysis of 12 cohorts involving 91,675 participants, we found 43 genomic loci associated with either hepcidin or sTfR concentration, of which 15 previously unreported. Mapping to putative genes indicated involvement in iron-trait expression, erythropoiesis, immune response and cellular trafficking. Mendelian randomisation of 292 disease outcomes in 1,492,717 participants revealed associations of iron-related loci and iron status with selected health outcomes across multiple domains. These associations were largely driven by HFE, which was associated with the largest iron variation. Our findings enhance understanding of iron homoeostasis and its biomedical consequences, suggesting that lifelong exposure to higher iron levels is likely associated with lower risk of anaemia-related disorders and higher risk of genitourinary, musculoskeletal, infectious and neoplastic diseases.

Ce résumé expose les affirmations des auteurs. BNTIC ne l’interprète pas comme une validation indépendante des résultats.

Contrôle bibliographique ouvert

DOI retrouvé dans Crossref DOI retrouvé ; titre concordant.

Titre Crossref
Novel loci and biomedical consequences of iron homoeostasis variation
Date Crossref
06/12/2024
Éditeur
Springer Science and Business Media LLC
Type
journal-article

Ce recoupement confirme des métadonnées liées au DOI. Il ne confirme ni la méthode ni les conclusions de l’étude et ne compte pas comme une seconde source scientifique indépendante.

Institutions déclarées

NHS Blood and TransplantUniversity of CambridgeLung InstituteCancer Research UK Cambridge CenterImperial College LondonHarvard UniversityVA Boston Healthcare SystemBrigham and Women's HospitalUniversidade Federal do ParanáInstitute for Molecular Medicine FinlanddeCODE Genetics (Iceland)University College LondonAddenbrooke's HospitalUniversity College London Hospitals NHS Foundation TrustCambridge University Hospitals NHS Foundation TrustChurchill HospitalJohn Radcliffe HospitalUniversity of OxfordCopenhagen University HospitalRigshospitaletUniversity of CopenhagenStatens Serum InstitutZealand University Hospital KøgeNovo Nordisk FoundationAarhus University HospitalUniversity of IcelandDanish Cancer SocietyAalborg University HospitalAalborg UniversityOdense University HospitalEurac ResearchInstitute for BiomedicineOspedale di BolzanoUniversity of VeronaFinnish Red CrossHelmholtz MunichDeutsches Diabetes-Zentrum e.V.German Center for Diabetes ResearchHeinrich Heine University DüsseldorfLudwig-Maximilians-Universität MünchenUniversity of SplitUniversity of EdinburghInstitute of Genetics and CancerMedical Research CouncilThe Queen's Medical Research InstituteHuman TechnopoleSanquinGGD AmsterdamNational Institute on AgingAzienda Sanitaria di FirenzeUniversity of TriesteIRCCS Materno Infantile Burlo GarofoloUniversity Medical Center GroningenUniversity of GroningenRegeneron (United States)University Medical Center UtrechtRadboud University NijmegenRadboud University Medical CenterBroad InstituteUniversity of HelsinkiMassachusetts General HospitalAbbVie (United States)AstraZeneca (United Kingdom)Biogen (United States)Boehringer Ingelheim (Germany)Bristol-Myers Squibb (United States)GlaxoSmithKline (United States)Glaxosmithkline (Finland)Merck & Co., Inc., Rahway, NJ, USA (United States)Pfizer (United States)Maze (United States)Janssen (United States)Novartis (United States)University of OuluUniversity of TurkuVarsinais-Suomen SairaanhoitopiiriFinnish Institute for Health and WelfareHospital District of Helsinki and UusimaaBorealis (Finland)Northern Ostrobothnia Hospital DistrictTampere UniversityPirkanmaa Hospital DistrictTampere UniversityUniversity of Eastern FinlandFinland UniversityCentral Finland Health Care DistrictUniversity of JyväskyläBusiness FinlandGlaxoSmithKline (United Kingdom)Seinäjoki University of Applied SciencesUniversity of GothenburgNovartis (Switzerland)Helsinki University HospitalUniversity of ŁódźFolkhälsans ForskningscentrumOulu University HospitalKuopio University HospitalStanford UniversityEuropean Bioinformatics InstituteBaker Heart and Diabetes InstituteHealth Data Research UKUniversity of South AustraliaSouth Australian Health and Medical Research InstituteTechnical University of MunichWellcome Sanger InstituteCambridge University Health Partners

Une affiliation ne permet pas de déduire la nationalité d’un auteur.

Sujets associés

Iron Metabolism and DisordersHemoglobinopathies and Related DisordersFolate and B Vitamins Research

BNTIC News n’est pas le producteur de ces données. Recherche à la demande dans Crossref, OpenAIRE, DOAJ, Europe PMC, HAL, DataCite, ROR et la Banque mondiale, sans clé ; OpenAlex reste optionnel. Aucun service payant requis, aucune donnée externe enregistrée en base. Sources et limites.